Alternately, in prostate cancer, butyrate has been shown to accelerate tumor progression by inducing autophagy and upregulating the chemokine CCL20 through TLR3 signaling, ultimately recruiting M2-like macrophages that support immune suppression [47]. The gene discussed is TLR3; the disease is prostate cancer.